G

GC Cell Corp
KOSDAQ:144510

Watchlist Manager
GC Cell Corp
KOSDAQ:144510
Watchlist
Price: 22 200 KRW 0.68% Market Closed
Market Cap: 350.8B KRW

Operating Margin

-39.3%
Current
Declining
by 34.4%
vs 3-y average of -4.9%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-39.3%
=
Operating Income
₩-66.8B
/
Revenue
₩170.1B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-39.3%
=
Operating Income
₩-66.8B
/
Revenue
₩170.1B

Peer Comparison

Country Company Market Cap Operating
Margin
KR
GC Cell Corp
KOSDAQ:144510
333.6B KRW
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
385.9B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
187.6B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
163.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119.4B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.7B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.4B AUD
Loading...
NL
argenx SE
XBRU:ARGX
42.7B EUR
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
48.8B USD
Loading...
No Stocks Found

Market Distribution

Lower than 91% of companies in Korea
Percentile
9th
Based on 2 615 companies
9th percentile
-39.3%
Low
-163 055.6% — -2.2%
Typical Range
-2.2% — 6.8%
High
6.8% — 22 874.8%
Distribution Statistics
Korea
Min -163 055.6%
30th Percentile -2.2%
Median 2.7%
70th Percentile 6.8%
Max 22 874.8%

GC Cell Corp
Glance View

Market Cap
350.8B KRW
Industry
Biotechnology

GC Cell Corp. engages in the research and development of cell curing agents and in the transport and sale of consignment inspection samples. The company is headquartered in Yongin, Gyeonggi-Do. The company went IPO on 2016-06-23. The firm operates its business through four segments. The Specimen Testing Service segment provides sample testing services, clinical trial services, and veterinary testing services. The Cell Therapy segment is engaged in cell culture and technology transfer business. The Cord Blood Storage segment is engaged in the cord blood storage business. The Other Business segment is engaged in bio-logistics business and others.

Intrinsic Value
24 013.71 KRW
Undervaluation 8%
Intrinsic Value
Price
G
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-39.3%
=
Operating Income
₩-66.8B
/
Revenue
₩170.1B
What is GC Cell Corp's current Operating Margin?

The current Operating Margin for GC Cell Corp is -39.3%, which is below its 3-year median of -4.9%.

How has Operating Margin changed over time?

Over the last 3 years, GC Cell Corp’s Operating Margin has decreased from 27.3% to -39.3%. During this period, it reached a low of -39.3% on Oct 30, 2025 and a high of 27.3% on Aug 30, 2022.

Back to Top